Share
Save
Skincubator, a Novel Incubator for Skin to Skin Contact Feasibility Study
The goal of this clinical trial is to test the feasibility of using the Skincubator, a wearable incubator for skin to skin contact of preterm babies and their parents. It will also learn about the safety of skincubator. The main questions it aims to answer are: * Can the Skincubator keep a stable temperature for the smallest babies and the first days after birth? * How many hours will the parents (and other family members) will succeed to perform skin to skin every day? Participants will: Be offered the opportunity to perform Skincubator care for as long as they want to each day during the week after enrolment.
Study details:
Study design: This is a non-randomized feasibility trial with no control group in which the investigators will offer parents the option to perform Skincubator care - being cared for in SSC inside the Skincubator, which is placed on the mother and/or another caregiver. Skincubator care will be provided from birth if the caring team and the parents feel it is appropriate. The option for Skincubator care will be provided for as long as the parents, surrogates, and staff feel comfortable with a goal of possible achievement of the WHO target of 8 hours per day.
Each infant will participate in the study for one week from enrollment (If parents desire, they will be able to continue using the Skincubator beyond 1 week as long as NICU staff feel that it is helpful for the baby). Implementation phase: Prior to beginning the study, each center will provide care in the Skincubator for five noninvasively ventilated preterm babies. After gaining experience in treating a preterm baby in the Skincubator and performing manikin simulations of Skincubator care for invasively ventilated babies, the NICU team in each center will be able to decide whether to include intubated babies in the trial.
Population: up to 25 preterm neonates in each site, born at GA of 24. 0-32. 6 with birth weight of \<1.
5 kg. First 3 babies will be of GA of 26-32. 6 and on noninvasive respiratory support.
Those babies will be considered a learning phase for the team, and may be analyzed separately. After completing the learning phase the study will proceed with 4 groups:. 1.
Up to 7 more babies of GA of 26-32. 6 and on noninvasive respiratory support. 2.
5 Intubated babies with GA of 26-32. 6. The investigators will start enrolling babies from this group only after the team treated at least 5 babies from group 1 (including the learning phase) and feels ready to move on to intubated babies.
3. 5 babies GA 24. 0-25.
6 on noninvasive respiratory support. The investigators will start enrolling babies from this group only after the team treated at least 5 babies from group 1 (including the learning phase) and feels ready to move on to this age group. 4.
5 intubated babies with GA of 24. 0-25. 6.
The investigators will start enrolling babies from this group only after the team treated at least 3 babies from group 2 and 3 babies from group 3, and only if the team feels ready to move on to this group also. First five babies will be treated in the Skincubator only from NICU admission. After gaining experience with the first 5 babies the team may decide to start Skincubator care in birth suite (ideally on the mother, potentially on the father if the mother prefers or is feeling unwell) or in cesarean section theater (on the father).
Eligibility criteria
Researchers look for people who fit a certain description, called eligibility criteria. See if you qualify.
Inclusion criteria
Exclusion criteria
Eligibility
Age eligible for study : 0 and older
Healthy volunteers accepted : No
Gender eligible for study: All
Things to know
Study dates
Study start: 2024-08-31
Primary completion: 2026-09-01
Study completion finish: 2027-09-01
Study type
TREATMENT
Phase
PHASE2
PHASE3
Trial ID
NCT06543433
Intervention or treatment
DEVICE: Skincubator 2
Conditions
- • Preterm Birth
- • Preterm
Find a site
Closest Location:
Monash Children's hospital
Research sites nearby
Select from list below to view details:
Monash Children's hospital
Clayton, Victoria, Australia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
| Participant Group/Arm | Intervention/Treatment |
|---|---|
EXPERIMENTAL: Skincubator
| DEVICE: Skincubator 2
|
What is the study measuring?
Primary outcome
| Primary Outcome Measure | Primary Outcome Description | Primary Outcome Time Frame |
|---|---|---|
| hours of SSC per day | primary neonatal outcome will be hours of SSC per day | In the first week from study commencement (study commencement will be defined as birth or receiving consent, whichever occurs later). |
| Parental Stress Scale (PSS) NICU | Parental Stress Scale (PSS) NICU performed by the mother. Minimum and maximum values for PSS NICU are 0 and 72, higher scoring indicates higher parental stress. | 4 to 7 days after birth. |
Secondary outcome
| Secondary Outcome Measure | Secondary Outcome Description | Secondary Outcome Time Frame |
|---|---|---|
| Time outside of temperature range 36.5-37.5 | Time outside of temperature range 36.5-37.5 measured axillary | In the first week from study commencement (study commencement will be defined as birth or receiving consent, whichever occurs later). |
| time in environmental humidity of less than 60% | time in environmental humidity of less than 60% measured by hygrometer and incubator hygrometer | In the first week from study commencement (study commencement will be defined as birth or receiving consent, whichever occurs later). |
Frequently Asked Questions
Please note: some questions and answers are submitted by anonymous patients or using AI, and have not been verified by Clinrol
No questions submitted. Be the first to ask a question!